AUGMENTIN 1gm In Skin And Soft Tissue Infection

GlaxoSmithKline (GSK)

Status and phase: Completed; Phase 4

Conditions: Skin Diseases, Infectious; Infection, Soft Tissue

Treatments: Drug: amoxicillin/clavulanate potassium 1gm

Study type: Interventional

Funder types: Industry

Identifiers

NCT00343135

103997

Details and patient eligibility

About

Study to evaluate the effects of AUGMENTIN 1gm in the treatment of Skin and Soft tissue infections

Enrollment: 195 patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• having diagnosed uncomplicated soft tissue infection (e.g furuncle, cellulitis)
• has given freely documented consent.

Exclusion criteria

• antibiotics
• have renal or hepatic insufficiency
• systemic toxicity
• pregnancy
• lactation
• hypersensitivity to penicillin or Beta-lactam antibiotics

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

195 participants in 1 patient group

ARM 1

Experimental group

Treatment:

Drug: amoxicillin/clavulanate potassium 1gm